CSPC Innovation Pharmaceutical Co Ltd Class A (300765)

Currency in CNY
52.51
-2.22(-4.06%)
Closed·
300765 Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
300765 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
52.2855.15
52 wk Range
21.0763.31
Key Statistics
Bid/Ask
52.51 / 52.53
Prev. Close
54.73
Open
54.2
Day's Range
52.28-55.15
52 wk Range
21.07-63.31
Volume
8.2M
Average Volume (3m)
10.36M
1-Year Change
102.61%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300765 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
51.40
Downside
-2.11%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

CSPC Innovation Pharmaceutical Co Ltd Class A Company Profile

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

Employees
2487
Market
China

Compare 300765 to Peers and Sector

Metrics to compare
300765
Peers
Sector
Relationship
P/E Ratio
−1,399.9x33.3x−0.5x
PEG Ratio
12.83−1.030.00
Price/Book
19.7x3.0x2.6x
Price / LTM Sales
37.9x4.2x3.2x
Upside (Analyst Target)
−8.0%9.7%44.1%
Fair Value Upside
Unlock2.8%6.2%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 51.40
(-2.11% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.04%
Dividend Yield
0.04%
Industry Median 2.36%
Annualised payout
0.02
Paid annually
5-Years Growth
-3.42%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
471.97M / --
EPS Revisions
Last 90 days

300765 Income Statement

FAQ

What Stock Exchange Does CSPC Innovation Trade On?

CSPC Innovation is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for CSPC Innovation?

The stock symbol for CSPC Innovation is "300765."

What Is the CSPC Innovation Market Cap?

As of today, CSPC Innovation market cap is 76.22B.

What Is CSPC Innovation's Earnings Per Share (TTM)?

The CSPC Innovation EPS (TTM) is -0.04.

When Is the Next CSPC Innovation Earnings Date?

CSPC Innovation will release its next earnings report on 15 Aug 2025.

From a Technical Analysis Perspective, Is 300765 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has CSPC Innovation Stock Split?

CSPC Innovation has split 4 times.

How Many Employees Does CSPC Innovation Have?

CSPC Innovation has 2487 employees.

What is the current trading status of CSPC Innovation (300765)?

As of 22 Jul 2025, CSPC Innovation (300765) is trading at a price of 52.51, with a previous close of 54.73. The stock has fluctuated within a day range of 52.28 to 55.15, while its 52-week range spans from 21.07 to 63.31.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.